Subscribe To
Tiziana life sciences to present ms treatment at ectrims annual congress
Tiziana Life sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of...
October 11, 2023, 9:26 am
Neurocrine's crinecerfont delivered, but the street has been slow to reward the success
Neurocrine Biosciences has reported very positive Phase III results for crinecerfont in adult and pedia...
October 11, 2023, 3:44 am
Synairgen appoints new cfo as incumbent bows out after nearly 20 years
Synairgen PLC (AIM:SNG, OTC:SYGGF) said Joseph Colliver will succeed John Ward as chief financial officer effective November 6. Colliver comes to Sy...
October 11, 2023, 2:47 am
Sellas receives fda orphan drug designation for sls009 for treatment of acute myeloid leukemia
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — SELLAS Life sciences Group, Inc. (NASDAQ: SLS) (“SELLAS�...
October 10, 2023, 8:15 pm
Why shares of ventyx biosciences are dropping tuesday
Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candidate is VTX002 to treat moderate-to-severe ul...
October 10, 2023, 12:55 pm
Bioharvest sciences announces health canada license for vinia sales in canada
BioHarvest sciences Inc. (CSE:BHSC, OTC:CNVCF) announced it has received a Canadian product license f...
October 10, 2023, 12:40 pm
10%-yielding hercules capital is a bdc superstar
Hercules Capital is a top-tier business development company with a strong track record and a high yield. The company specializes in financing high-gro...
October 10, 2023, 11:00 am
A bull market is coming: 1 beaten-down growth stock you could regret not buying on the dip
Caribou Biosciences stock could rocket up more than 400%, according to the consensus price target from ...
October 10, 2023, 5:40 am
Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against pacwest, integra, and enviva and encourages investors to contact the firm
NEW YORK, Oct. 09, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ...
October 10, 2023, 1:00 am
Ibn and biomedwire named official media partners for biopharma nexus events in october 2023
LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) — via InvestorWire — InvestorBrandNetwork (“IBN”), a dynamic communications organization, is delig...
October 9, 2023, 1:35 pm
Anavex: the september data
Anavex Life sciences Corp. presented follow-on data from its Alzheimer's disease trial. This data uses ...
October 9, 2023, 11:37 am
Bet on these 4 top-ranked liquid stocks for robust returns
Here are four top-performing liquid stocks, Neurocrine Biosciences (NBIX), GigaCloud Technology (GCT), ...
October 9, 2023, 9:01 am
Exact sciences schedules third quarter 2023 earnings call
MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact sciences Corp. (Nasdaq: EXAS), a leading provider of...
October 9, 2023, 6:00 am
Exact sciences to present late-breaking data from pivotal blue-c study on next-generation cologuard at acg 2023
MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact sciences Corp. (NASDAQ: EXAS), a leading provider o...
October 9, 2023, 5:58 am
Rosen, a top ranked law firm, encourages integra lifesciences holdings corporation investors to secure counsel before important deadline in securities class action – iart
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra Lif...
October 8, 2023, 11:11 pm
Bmez: healthy 8% yield, big 17% discount, ~8 years to 'maturity'
BlackRock Health sciences Term Trust announced a distribution cut, and this unique CEF now trades at an...
October 8, 2023, 6:00 pm
Which is the better cancer-testing healthcare stock: exact sciences or guardant health?
Exact sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five yea...
October 8, 2023, 7:30 am
Columbus mckinnon undervalued as near-term capex pressures obscure the long-term growth opportunities
Columbus McKinnon's shares have declined about 10% this year, as companies have pulled back on investments in factory and logistics automation in the ...
October 7, 2023, 11:54 pm
Alpine immune sciences: november 2023 data release could get ball rolling
Preliminary clinical data from the Alpine Immune Sciences, Inc. ongoing phase 3 RUBY-3 study will be presented at the American Society of Nephrology A...
October 6, 2023, 3:31 pm
Why shares of cassava sciences soared this week
A rash of insider buying helped buoy the clinical-stage biotech's stock. Cassava said it had completed the enrollment of a phase 3 trial for an Alzhei...
October 6, 2023, 3:13 pm